Fibrinogen replacement therapy: a critical review of the literature

被引：115

作者：

Franchini, Massimo ^{[1
]}

Lippi, Giuseppe ^{[2
]}

机构：

[1] Univ Hosp Parma, Dept Pathol & Lab Med, Serv Immunohaematol & Transfus Med, Parma, Italy

[2] Univ Hosp Parma, Dept Pathol & Lab Med, Unit Blood Chem Diagnost, Parma, Italy

来源：

BLOOD TRANSFUSION | 2012年 / 10卷 / 01期

关键词：

cryoprecipitate; fibrinogen concentrate; hypofibrinogenaemia; bleeding; replacement therapy; FRESH-FROZEN PLASMA; HYDROXYETHYL STARCH; CONCENTRATE; CRYOPRECIPITATE; MANAGEMENT; PHARMACOKINETICS; TOLERABILITY; DEFICIENCY; GUIDELINES; DISORDERS;

D O I：

10.2450/2011.0015-11

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：23 / 27

页数：5

共 33 条

[1] Rare inherited disorders of fibrinogen
Acharya, S. S.
Dimichele, D. M.
[J]. HAEMOPHILIA, 2008, 14 (06) : 1151 - 1158
[2] [Anonymous], 2009, Transfus Med Hemother, V36, P419
[3] Influence of methylene blue photoinactivation treatment on coagulation factors from fresh frozen plasma, cryoprecipitates and cryosupernatants
Aznar, JA
Bonanad, S
Montoro, JM
Hurtado, C
Cid, AR
Soler, MA
De Miguel, A
[J]. VOX SANGUINIS, 2000, 79 (03) : 156 - 160
[4] The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage
Bell, S. F.
Rayment, R.
Collins, P. W.
Collis, R. E.
[J]. INTERNATIONAL JOURNAL OF OBSTETRIC ANESTHESIA, 2010, 19 (02) : 218 - 223
[5] Cryoprecipitate: no longer the best therapeutic choice in congenital fibrinogen disorders?
Bevan, David H.
[J]. THROMBOSIS RESEARCH, 2009, 124 : S12 - S16
[6] The rare coagulation disorders - review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation
Bolton-Maggs, PHB
Perry, DJ
Chalmers, EA
Parapia, LA
Wilde, JT
Williams, MD
Collins, PW
Kitchen, S
Dolan, G
Mumford, AD
[J]. HAEMOPHILIA, 2004, 10 (05) : 593 - 628
[7] Preparation and viral inactivation of cryoprecipitate in blood banks in resource-limited countries
Burnouf, T.
Goubran, H. A.
Radosevich, M.
El-Ekiaby, M.
[J]. ISBT SCIENCE SERIES, VOL 2, NO 2: STATE OF THE ART PRESENTATIONS, 2007, 2 (02): : 121 - +
[8] Animal model and clinical evidence indicating low thrombogenic potential of fibrinogen concentrate (Haemocomplettan P)
Dickneite, Gerhard
Pragst, Ingo
Joch, Christine
Bergman, Garrett E.
[J]. BLOOD COAGULATION & FIBRINOLYSIS, 2009, 20 (07) : 535 - 540
[9] Efficacy and tolerability of human fibrinogen concentrate administration to patients with acquired fibrinogen deficiency and active or in high-risk severe bleeding
Farriols Danes, A.
Gallur Cuenca, L.
RodrIguez Bueno, S.
Mendarte Barrenechea, L.
Montoro Ronsano, J. Bruno
[J]. VOX SANGUINIS, 2008, 94 (03) : 221 - 226
[10] Mechanisms of hydroxyethyl starch-induced dilutional coagulopathy
Fenger-Eriksen, C.
Tonnesen, E.
Ingerslev, J.
Sorensen, B.
[J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (07) : 1099 - 1105

← 1 2 3 4 →